Anthem Inc (NYSE:ANTM) Director Robert L. Dixon, Jr. sold 520 shares of the firm’s stock in a transaction on Friday, July 26th. The shares were sold at an average price of $294.11, for a total value of $152,937.20. Following the transaction, the director now owns 9,971 shares in the company, valued at $2,932,570.81. The sale was disclosed in a document filed with the SEC, which is available at this link.

Shares of NYSE ANTM traded up $1.32 during mid-day trading on Tuesday, reaching $299.64. 680,890 shares of the company’s stock were exchanged, compared to its average volume of 1,778,916. The firm has a market cap of $76.32 billion, a price-to-earnings ratio of 18.86, a price-to-earnings-growth ratio of 1.11 and a beta of 0.70. Anthem Inc has a 52 week low of $227.16 and a 52 week high of $317.99. The company has a quick ratio of 1.64, a current ratio of 1.64 and a debt-to-equity ratio of 0.57. The stock has a 50-day moving average price of $291.66.

Anthem (NYSE:ANTM) last released its earnings results on Wednesday, July 24th. The company reported $4.64 EPS for the quarter, topping the Zacks’ consensus estimate of $4.61 by $0.03. The company had revenue of $25.20 billion for the quarter, compared to analysts’ expectations of $24.88 billion. Anthem had a return on equity of 15.02% and a net margin of 4.21%. The business’s revenue for the quarter was up 10.9% compared to the same quarter last year. During the same period in the previous year, the business posted $4.25 EPS. On average, analysts expect that Anthem Inc will post 19.35 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 25th. Stockholders of record on Tuesday, September 10th will be paid a dividend of $0.80 per share. This represents a $3.20 dividend on an annualized basis and a dividend yield of 1.07%. The ex-dividend date is Monday, September 9th. Anthem’s payout ratio is 20.14%.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. NuWave Investment Management LLC increased its holdings in Anthem by 46.3% in the 2nd quarter. NuWave Investment Management LLC now owns 120 shares of the company’s stock worth $34,000 after acquiring an additional 38 shares during the last quarter. Sonora Investment Management LLC increased its holdings in Anthem by 38.0% in the 2nd quarter. Sonora Investment Management LLC now owns 138 shares of the company’s stock worth $39,000 after acquiring an additional 38 shares during the last quarter. Convergence Investment Partners LLC increased its holdings in Anthem by 4.2% in the 2nd quarter. Convergence Investment Partners LLC now owns 943 shares of the company’s stock worth $266,000 after acquiring an additional 38 shares during the last quarter. Brighton Jones LLC increased its holdings in Anthem by 3.7% in the 1st quarter. Brighton Jones LLC now owns 1,082 shares of the company’s stock worth $311,000 after acquiring an additional 39 shares during the last quarter. Finally, Advantage Investment Management LLC increased its holdings in Anthem by 10.1% in the 2nd quarter. Advantage Investment Management LLC now owns 458 shares of the company’s stock worth $129,000 after acquiring an additional 42 shares during the last quarter. Institutional investors own 87.38% of the company’s stock.

ANTM has been the topic of several recent analyst reports. SunTrust Banks restated a “hold” rating and set a $44.00 price objective on shares of Shutterstock in a research note on Thursday, April 25th. Barclays raised their price objective on T. Rowe Price Group from $90.00 to $95.00 and gave the company an “underweight” rating in a research note on Thursday, April 25th. Wells Fargo & Co set a $107.00 price objective on Valero Energy and gave the company a “buy” rating in a research note on Friday. Cantor Fitzgerald restated a “buy” rating and set a $75.00 price objective on shares of Emergent Biosolutions in a research note on Sunday, April 21st. Finally, Zacks Investment Research cut G1 Therapeutics from a “buy” rating to a “hold” rating in a research note on Thursday, May 16th. Two research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of $325.67.

Anthem Company Profile

Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets.

Recommended Story: How does new data get added to a blockchain?

Insider Buying and Selling by Quarter for Anthem (NYSE:ANTM)

Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.